Study explores intratumoral microbiota as a novel frontier in cancer research

Participants in a phase I trial lost a placebo-adjusted 6.1% of their body weight after 4 weeks of treatment with the investigational oral GLP-1 receptor

Gene ther­a­py pi­o­neer Jim Wil­son will leave his aca­d­e­m­ic post at the Uni­ver­si­ty of Penn­syl­va­nia and launch two new com­pa­nies, one fo­cused on de­vel­op­ing rare